Advertisement
CL vs KMB
Which Stock Would AI Choose? Colgate-Palmolive (CL) vs. Kimberly-Clark (KMB) Stock Comparison
Key Takeaways
- CL (Colgate-Palmolive) is leveraging emerging-market momentum and its oral care and pet nutrition leadership, but faces North America softness and rising input-cost and tariff pressures.
- KMB (Kimberly-Clark) is executing a large-scale transformation through its pending Kenvue acquisition and Suzano joint venture, while absorbing near-term China and cost headwinds.
- CL trades at a premium forward valuation (roughly 22–23x earnings) versus KMB's more moderate multiple (roughly 17–18x), reflecting differing growth and restructuring narratives.
- KMB offers a notably higher dividend yield (around 4.6–4.8%) as a long-running dividend aristocrat, while CL carries a lower yield but a steadier organic growth profile.
- Both are defensive consumer staples, yet their catalysts diverge: CL is driven by pricing, innovation, and emerging markets, while KMB is driven by M&A (mergers and acquisitions) integration and portfolio reshaping.
- For more detail on each name, explore CL Major News and CL Today's Price Move, as well as KMB Major News and KMB Today's Price Move.
- To see how AI-powered trading systems are positioning across this and other names, visit Trending AI Robots.
Introduction
Colgate-Palmolive (CL) and Kimberly-Clark (KMB) are two of the most established names in the consumer staples sector, yet they offer investors distinctly different profiles. CL is a global leader in oral care and pet nutrition, while KMB anchors its business in personal care, tissue, and hygiene brands such as Huggies, Kleenex, and Cottonelle. This stock comparison is relevant for investors weighing defensive, income-generating equities against momentum, growth catalysts, and restructuring risk. In the current environment of cost inflation, shifting consumer demand, and strategic repositioning, understanding the relative performance and market positioning of these two household names can help traders and long-term investors alike evaluate which better fits their objectives.
CL Overview and Recent Performance
Colgate-Palmolive generates the bulk of its revenue from oral care, where it holds leading global share positions in toothpaste and manual toothbrushes, alongside its fast-growing Hill's Pet Nutrition business. Recent market activity has reflected a rotation toward defensive consumer names, supporting CL's share price through the year. The company has posted broad-based sales growth, with its most recent quarters showing organic sales gains led by emerging markets including India, Brazil, Mexico, and China, while Hill's Pet Nutrition has continued to outperform its category.
However, sentiment has been tempered by persistent challenges. North America has been a relative weak spot, with softer category trends, heightened competition, and retailer inventory reductions pressuring results. Management has also flagged rising raw-material, packaging, and logistics costs, partly tied to global geopolitical tensions and tariff exposure. CL has responded by raising its quarterly dividend and expanding a cost-savings and productivity program, while leaning on pricing, premium innovation, and emerging-market volume growth. The result is a mixed narrative: consistent global execution offset by regional softness and margin scrutiny.
KMB Overview and Recent Performance
Kimberly-Clark operates across personal care, consumer tissue, and professional hygiene, with brands including Huggies, Kleenex, Kotex, and Cottonelle. The company is in the midst of a significant transformation, having announced a pending acquisition of Kenvue's consumer health portfolio and a joint venture with Suzano for its international tissue business. Recent performance has been resilient but uneven. While adjusted earnings per share have generally beaten expectations, organic sales growth has been roughly flat, weighed down by a disruption in China tied to social media claims about diaper quality and by the exit of its low-margin private-label diaper business.
Preliminary third-quarter results pointed to a modest decline in organic sales and a slight pullback in adjusted operating margin, though management reaffirmed its full-year outlook. Cost inflation, logistics pressures, and integration expenses remain key risks. On the positive side, KMB's productivity program is delivering savings, and the company continues to return capital to shareholders through a dividend it has increased for more than five decades. The stock's valuation reflects both the uncertainty of the pending Kenvue integration and the appeal of its income profile.
Trending AI Robots
Tickeron maintains hundreds of AI Trading Bots that collectively monitor and trade thousands of different tickers, each built with its own trading style, strategy, timeframe, performance record, and statistical profile. Because market conditions change continuously, only a select subset of these bots is well-suited to the current environment. Tickeron's Trending AI Robots page curates that narrower group, highlighting the systems that are demonstrating the strongest alignment with present market dynamics. Whether a trader prefers shorter-term signals or longer-horizon trend-following approaches, this page offers a focused view of the bots currently standing out. Investors comparing names like CL and KMB may find it useful to observe how these AI systems are positioning across the broader market.
Head-to-Head Comparison
Although both companies are consumer staples, their business models and growth drivers differ meaningfully. CL is more globally diversified and derives a meaningful portion of its growth from emerging markets and the higher-growth pet nutrition category, giving it a relatively organic, innovation-led trajectory. KMB is more concentrated in North America and is pursuing growth through M&A and portfolio restructuring, a path that offers scale and synergy potential but also introduces integration and execution risk.
On valuation, CL commands a premium multiple, reflecting its steadier organic growth and category leadership, while KMB trades at a discount, partly reflecting the uncertainty surrounding its pending Kenvue transaction. On income, KMB stands out with a higher dividend yield and an exceptionally long record of payout increases, whereas CL offers a lower yield with a modestly growing dividend. From a momentum and sentiment standpoint, CL has benefited from defensive rotation and emerging-market strength, while KMB's shares have contended with China-related disruption and softer organic sales. Risk profiles also diverge: CL's chief risks are input-cost inflation, tariffs, and North American competition, while KMB's center on integration complexity, demand disruption, and execution across its transformation initiatives.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI framework would currently lean toward CL for its more consistent trend and organic growth trajectory. The combination of broad emerging-market momentum, category leadership, a stable dividend, and a clearer near-term catalyst path gives CL a comparatively smoother fundamental backdrop. KMB presents an attractive valuation and a higher income yield, but its heavier reliance on M&A integration and ongoing China-related headwinds introduces greater uncertainty. Accordingly, the AI would likely favor CL on trend consistency and relative positioning, while acknowledging KMB's appeal for income-oriented investors willing to accept elevated restructuring risk. This assessment reflects probabilistic, data-driven reasoning rather than a definitive forecast.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CL is a Buy and KMB is a Buy.
CL in upward trend: 10-day moving average moved above 50-day moving average on October 16, 2026
The 10-day moving average for CL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 29 of 59 cases where CL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on CL as a result. In 30 of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 44%.
The Moving Average Convergence Divergence (MACD) for CL just turned positive on October 06, 2026. Looking at past instances where CL's MACD turned positive, the stock continued to rise in 22 of 43 cases over the following month. The odds of a continued upward trend are 51%.
CL moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where CL advanced for three days, in 145 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
The Aroon Indicator entered an Uptrend today. In 118 of 277 cases where CL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 43%.
Bearish Trend Analysis
The 10-day RSI Indicator for CL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 15 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 38%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
CL broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (321.875) is very high in comparison to the industry average of (20.608). P/E Ratio (37.516) is within average values for comparable stocks, (17.011). Projected Growth (PEG Ratio) (1.577) is also within normal values, averaging (1.518). Dividend Yield (0.022) settles around the average of (0.033) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (1.902).
KMB's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for KMB turned positive on October 06, 2026. Looking at past instances where KMB's MACD turned positive, the stock continued to rise in 25 of 44 cases over the following month. The odds of a continued upward trend are 57%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on KMB as a result. In 39 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 44%.
KMB moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for KMB crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 31%.
Following a +6.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where KMB advanced for three days, in 128 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 42%.
Bearish Trend Analysis
The 10-day RSI Indicator for KMB moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 21 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 23 of 46 cases where KMB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
KMB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for KMB entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. KMB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.513) is normal, around the industry mean (20.608). P/E Ratio (18.326) is within average values for comparable stocks, (17.011). Projected Growth (PEG Ratio) (2.018) is also within normal values, averaging (1.518). Dividend Yield (0.047) settles around the average of (0.033) among similar stocks. P/S Ratio (1.971) is also within normal values, averaging (1.902).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
CL | KMB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 46 | 100 | |
SMR RATING 1..100 | 8 | 12 | |
PRICE GROWTH RATING 1..100 | 29 | 45 | |
P/E GROWTH RATING 1..100 | 7 | 73 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KMB's Valuation (80) in the Household Or Personal Care industry is in the same range as CL (99). This means that KMB’s stock grew similarly to CL’s over the last 12 months.
CL's Profit vs Risk Rating (46) in the Household Or Personal Care industry is somewhat better than the same rating for KMB (100). This means that CL’s stock grew somewhat faster than KMB’s over the last 12 months.
CL's SMR Rating (8) in the Household Or Personal Care industry is in the same range as KMB (12). This means that CL’s stock grew similarly to KMB’s over the last 12 months.
CL's Price Growth Rating (29) in the Household Or Personal Care industry is in the same range as KMB (45). This means that CL’s stock grew similarly to KMB’s over the last 12 months.
CL's P/E Growth Rating (7) in the Household Or Personal Care industry is significantly better than the same rating for KMB (73). This means that CL’s stock grew significantly faster than KMB’s over the last 12 months.
| CL | KMB | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 38% | 3 days ago 57% |
| Stochastic ODDS (%) | 3 days ago 49% | 3 days ago 50% |
| Momentum ODDS (%) | 3 days ago 44% | 3 days ago 44% |
| MACD ODDS (%) | 3 days ago 51% | 3 days ago 57% |
| TrendWeek ODDS (%) | 3 days ago 50% | 3 days ago 53% |
| TrendMonth ODDS (%) | 3 days ago 51% | 3 days ago 41% |
| Advances ODDS (%) | 3 days ago 46% | 17 days ago 42% |
| Declines ODDS (%) | 5 days ago 47% | 5 days ago 51% |
| BollingerBands ODDS (%) | 3 days ago 41% | 3 days ago 53% |
| Aroon ODDS (%) | 3 days ago 43% | 3 days ago 32% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CL’s FA Score shows that 3 FA rating(s) are green while KMB’s FA Score has 1 green FA rating(s).
- CL’s FA Score: 3 green, 2 red.
- KMB’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CL’s TA Score shows that 7 TA indicator(s) are bullish while KMB’s TA Score has 5 bullish TA indicator(s).
- CL’s TA Score: 7 bullish, 3 bearish.
- KMB’s TA Score: 5 bullish, 5 bearish.
Price Growth
CL (@Household/Personal Care) experienced а +1.33% price change this week, while KMB (@Household/Personal Care) price change was -2.01% for the same time period.
The average weekly price growth across all stocks in the @Household/Personal Care industry was -1.30%. For the same industry, the average monthly price growth was +1.11%, and the average quarterly price growth was +9.01%.
Reported Earning Dates
CL is expected to report earnings on Jan 22, 2027.
KMB is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Household/Personal Care (-1.30% weekly)Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
Advertisement
CL and
Correlation & Price change
A.I.dvisor indicates that over the last year, CL has been closely correlated with PG. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CL jumps, then PG could also see price increases.
KMB and
Correlation & Price change
A.I.dvisor indicates that over the last year, KMB has been loosely correlated with CL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KMB jumps, then CL could also see price increases.